Colorectal Cancer News and reporting on colorectal cancer. Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors. Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research Indivumed and the Oslo University Hospital's Institute for Cancer Genetics and Informatics will develop algorithms to automate colorectal cancer prognoses. Aiming to Cut Unnecessary Surgeries, City of Hope Team to Commercialize CRC Metastasis Dx Signature Premium The team will use the reverse-transcriptase quantitative PCR test, which uses a milliliter of a patient's blood, to curb unneeded radical colon cancer surgeries. Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer The assay is intended to detect Guardant Health Receives New York State Approval for Guardant Reveal MRD Test The assay is Guardant Health’s first commercially available product for clinical management of early-stage tumors and is initially focused on colorectal cancer. May 4, 2016 Exact Sciences Stock Downgraded in Wake of Q1 Earnings Report May 3, 2016 UPDATE: Exact Sciences Revenues Up More Than Twofold on Cologuard Sales Apr 15, 2016 Expansion of Liquid Biopsy Test Sites Planned by Merck KGaA, Sysmex Premium Apr 14, 2016 Colorectal Tumors with High Predicted Neoantigen Loads Correlate with Better Survival Apr 13, 2016 FDA Approves Epigenomics' Blood-Based Colorectal Cancer Screening Test Apr 7, 2016 Merck KGaA, Sysmex Inostics Garner CE Mark for Liquid Biopsy CRC Test Apr 7, 2016 VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays Apr 4, 2016 Agena Receives CE-IVD Marking, Launches MassArray Cancer Tests in Europe Mar 31, 2016 JTS Health Takes Equity Position in GeneNews Mar 22, 2016 Clinical Genomics Raises $15M in Series A Financing Round Mar 18, 2016 Epigenomics FY 2015 Revenues Jump on Product Sales Mar 17, 2016 Applied Proteomics Encouraged by Early Sales of CRC Test Premium Feb 25, 2016 Anthem BCBS Georgia, Virginia to Cover Exact Sciences' Cologuard Test Feb 24, 2016 Team Ties Tumor Microenvironment to Metastasis in Colorectal Cancer Feb 24, 2016 UPDATE: Exact Sciences Q4 Revenues Balloon on Cologuard Sales Feb 22, 2016 Exact Sciences Sues BCBS of North Carolina for Refusing to Pay Cologuard Claims Feb 16, 2016 Exact v Humana Lawsuit Reflects Genetic Testing Firms' Deepening Adversarial Relations With Payors Premium Feb 9, 2016 Exact Sues Humana for Denying Cologuard Payment Feb 4, 2016 URMC Inks Deal With Indivumed to Create Cancer Tissue Bank Feb 3, 2016 Amgen to Offer Biocartis RAS Biomarker Tests in Select Countries Load More Breaking News Seven Bridges, ZS Genetics Partner for Multiomics Analytics in Drug Development BioMérieux Receives CE Mark for Vitek Clinical Microbiology Mass Spec System People in the News: New Appointments at Helix, Fulgent Genetics, IDbyDNA, Quantum-Si, More New Products Posted to GenomeWeb: Centogene, Meridian Bioscience, Oxford Nanopore, More Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research Cystic Fibrosis-Related Airway Cell Changes Revealed in Single-Cell Transcriptome Study The Scan Pfizer-BioNTech Seek Full Vaccine Approval According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine. Viral Integration Study Critiqued Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism. Giraffe Species Debate The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it. Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.